Board Meeting7 Aug 2026, 06:30 pm
Eiko Lifesciences Board Meeting on Aug 12 to Approve Q1 FY27 Results
AI Summary
Eiko Lifesciences Ltd has announced a Board of Directors meeting scheduled for August 12, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the meeting will address any other matters with the chair's permission. The company has also confirmed that the trading window for designated persons remains closed from July 1, 2026, until 48 hours after the financial results are declared.
Key Highlights
- Board meeting scheduled for August 12, 2026.
- To approve unaudited standalone and consolidated financial results for Q1 FY27.
- Trading window remains closed for designated persons.
- Compliance with SEBI Listing Obligations and Disclosure Requirements.
Price Impact
More from EIKO